Dexcom Inc Stock Market Value
| DXCM Stock | USD 70.16 0.19 0.27% |
| Symbol | DexCom |
Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.099 | Earnings Share 1.8 | Revenue Per Share | Quarterly Revenue Growth 0.216 | Return On Assets |
Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value - what DexCom's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in DexCom on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 90 days. DexCom is related to or competes with STERIS Plc, Insulet, Zimmer Biomet, Koninklijke Philips, Smith Nephew, Laboratory, and Waters. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.85 | |||
| Information Ratio | 0.0667 | |||
| Maximum Drawdown | 8.87 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 3.29 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.1007 | |||
| Jensen Alpha | 0.156 | |||
| Total Risk Alpha | 0.0056 | |||
| Sortino Ratio | 0.0688 | |||
| Treynor Ratio | 0.3199 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1007 | |||
| Market Risk Adjusted Performance | 0.3299 | |||
| Mean Deviation | 1.4 | |||
| Semi Deviation | 1.6 | |||
| Downside Deviation | 1.85 | |||
| Coefficient Of Variation | 845.03 | |||
| Standard Deviation | 1.91 | |||
| Variance | 3.63 | |||
| Information Ratio | 0.0667 | |||
| Jensen Alpha | 0.156 | |||
| Total Risk Alpha | 0.0056 | |||
| Sortino Ratio | 0.0688 | |||
| Treynor Ratio | 0.3199 | |||
| Maximum Drawdown | 8.87 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 3.29 | |||
| Downside Variance | 3.41 | |||
| Semi Variance | 2.55 | |||
| Expected Short fall | (1.43) | |||
| Skewness | 0.3247 | |||
| Kurtosis | 1.38 |
DexCom Inc Backtested Returns
DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.18, which denotes the company had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Downside Deviation of 1.85, coefficient of variation of 845.03, and Mean Deviation of 1.4 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DexCom holds a performance score of 14. The firm shows a Beta (market volatility) of 0.67, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether DexCom's price patterns will revert.
Auto-correlation | 0.79 |
Good predictability
DexCom Inc has good predictability. Overlapping area represents the amount of predictability between DexCom time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of 0.79 indicates that around 79.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 5.2 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out DexCom Correlation, DexCom Volatility and DexCom Performance module to complement your research on DexCom. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.